# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3369821 | F | Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as cell protection after 72 hrs by cytopathic effect assay | Influenza A virus | 37 | organism-based format | Scientific Literature | ||
2. | ALA3369822 | F | Antiviral activity against Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in cells assessed as reduction in multiplication of virus-specific RNA molecules using branched-chain DNA | Influenza A virus | 36 | organism-based format | Scientific Literature | ||
3. | ALA3369823 | B | Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assay | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | 30 | single protein format | Scientific Literature | ||
4. | ALA3369824 | A | Clearance in rat at 3 mg/kg, iv | Rattus norvegicus | 13 | organism-based format | Scientific Literature | ||
5. | ALA3369825 | A | Half life in rat at 3 mg/kg, iv | Rattus norvegicus | 9 | organism-based format | Scientific Literature | ||
6. | ALA3369826 | A | AUC in rat at 3 mg/kg, po | Rattus norvegicus | 6 | organism-based format | Scientific Literature | ||
7. | ALA3369827 | A | Cmax in rat at 3 mg/kg, po | Rattus norvegicus | 6 | organism-based format | Scientific Literature | ||
8. | ALA3369828 | A | Oral bioavailability in rat at 3 mg/kg | Rattus norvegicus | 6 | organism-based format | Scientific Literature | ||
9. | ALA3369829 | A | AUC in mouse at 30 mg/kg | Mus musculus | 6 | organism-based format | Scientific Literature | ||
10. | ALA3369830 | A | Cmax in mouse at 30 mg/kg | Mus musculus | 6 | organism-based format | Scientific Literature |